These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 32727800)
1. Adoptive Immune-Cell Therapy for the Treatment of Neuroendocrine Carcinoma of the Uterine Cervix. Goto S; Terao Y; Kamigaki T; Takimoto R; Naitoh K; Makita K; Yasumoto K; Okada S; Takizawa K; Yokomichi N; Suzuki N; Takeda S Anticancer Res; 2020 Aug; 40(8):4741-4748. PubMed ID: 32727800 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine carcinoma of the cervix: a systematic review of the literature. Tempfer CB; Tischoff I; Dogan A; Hilal Z; Schultheis B; Kern P; Rezniczek GA BMC Cancer; 2018 May; 18(1):530. PubMed ID: 29728073 [TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence and survival in neuroendocrine cervical cancer. Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621 [TBL] [Abstract][Full Text] [Related]
4. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210 [TBL] [Abstract][Full Text] [Related]
5. Natural history and outcome of neuroendocrine carcinoma of the cervix. Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865 [TBL] [Abstract][Full Text] [Related]
6. Distant organ metastasis patterns and prognosis of neuroendocrine cervical carcinoma: a population-based retrospective study. Li Q; Yu J; Yi H; Lan Q Front Endocrinol (Lausanne); 2022; 13():924414. PubMed ID: 36051393 [TBL] [Abstract][Full Text] [Related]
7. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix. Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine carcinoma of the uterine cervix: a single institution case review. Niu X; Gilbert L Eur J Gynaecol Oncol; 2011; 32(4):377-80. PubMed ID: 21941956 [TBL] [Abstract][Full Text] [Related]
9. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study. Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806 [TBL] [Abstract][Full Text] [Related]
10. Imaging and staging of neuroendocrine cervical cancer. Elsherif S; Odisio EGLC; Faria S; Javadi S; Yedururi S; Frumovitz M; Ramalingam P; Bhosale P Abdom Radiol (NY); 2018 Dec; 43(12):3468-3478. PubMed ID: 29974177 [TBL] [Abstract][Full Text] [Related]
11. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655 [TBL] [Abstract][Full Text] [Related]
12. PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer. Ji X; Sui L; Song K; Lv T; Zhao H; Yao Q Cancer Med; 2021 Jul; 10(14):4743-4751. PubMed ID: 34076351 [TBL] [Abstract][Full Text] [Related]
13. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review. Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556 [TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix]. Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373 [TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease]. Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410 [TBL] [Abstract][Full Text] [Related]
16. The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis. Kim C; Salvo G; Ishikawa M; Chen TC; Jhingran A; Bhosale P; Ramalingam P; Frumovitz M Gynecol Oncol; 2023 Mar; 170():328-332. PubMed ID: 36773379 [TBL] [Abstract][Full Text] [Related]
17. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population. Zhang X; Lv Z; Lou H BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631 [TBL] [Abstract][Full Text] [Related]
18. Surgical treatment for neuroendocrine carcinoma of the uterine cervix. Kasamatsu T; Sasajima Y; Onda T; Sawada M; Kato T; Tanikawa M Int J Gynaecol Obstet; 2007 Dec; 99(3):225-8. PubMed ID: 17897648 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review. Wang Y; Mei K; Xiang MF; Li JM; Xie RM Eur J Gynaecol Oncol; 2013; 34(4):307-10. PubMed ID: 24020135 [TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine carcinoma of the uterine cervix: A clinicopathologic retrospective study of 31 cases with prognostic implications. Wang KL; Yang YC; Wang TY; Chen JR; Chen TC; Chen HS; Su TH; Wang KG J Chemother; 2006 Apr; 18(2):209-16. PubMed ID: 16736891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]